BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19889125)

  • 1. IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.
    Wei B; Baker S; Wieckiewicz J; Wood KJ
    Am J Transplant; 2010 Jan; 10(1):69-80. PubMed ID: 19889125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
    Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
    Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).
    Gurram RK; Kujur W; Maurya SK; Agrewala JN
    J Biol Chem; 2014 Jun; 289(25):17515-28. PubMed ID: 24811173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.
    Ma H; Lu C; Ziegler J; Liu A; Sepulveda A; Okada H; Lentzsch S; Mapara MY
    J Clin Invest; 2011 Jul; 121(7):2554-69. PubMed ID: 21670504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.
    Paunicka K; Chen PW; Niederkorn JY
    J Leukoc Biol; 2012 Mar; 91(3):475-83. PubMed ID: 22180630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1.
    Wu X; Shao F; Yang Y; Gu L; Zheng W; Wu X; Gu Y; Shu Y; Sun Y; Xu Q
    Int Immunopharmacol; 2014 Dec; 23(2):434-41. PubMed ID: 25261409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines affecting CD4
    Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM
    Transpl Immunol; 2017 Jun; 42():24-33. PubMed ID: 28487237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.
    Sawitzki B; Kingsley CI; Oliveira V; Karim M; Herber M; Wood KJ
    J Exp Med; 2005 Jun; 201(12):1925-35. PubMed ID: 15967822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
    Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
    Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
    Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
    Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating Foxp3(+) regulatory T cells from spontaneously tolerant kidney allografts demonstrate donor-specific tolerance.
    Hu M; Wang C; Zhang GY; Saito M; Wang YM; Fernandez MA; Wang Y; Wu H; Hawthorne WJ; Jones C; O'Connell PJ; Sparwasser T; Bishop GA; Sharland AF; Alexander SI
    Am J Transplant; 2013 Nov; 13(11):2819-30. PubMed ID: 24102948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis.
    Chang JH; Kim YJ; Han SH; Kang CY
    Eur J Immunol; 2009 May; 39(5):1241-51. PubMed ID: 19337996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
    Rothfuchs AG; Trumstedt C; Mattei F; Schiavoni G; Hidmark A; Wigzell H; Rottenberg ME
    J Immunol; 2006 Jun; 176(11):6982-90. PubMed ID: 16709859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway.
    Gao X; Yang H; Xu Y; Xiong Y; Wang G; Ye X; Ye J
    Int Immunopharmacol; 2014 Dec; 23(2):688-95. PubMed ID: 25445961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
    Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
    Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.